Newsroom

The latest news and updates from Oncopeptides

In the spotlight

May 8, 2026

In this premiere episode of Oncopeptalks in a brand-new podcast format, we sit down with Sofia Heigis, CEO of Oncopeptides, to discuss the company’s core mission, and what it actually takes to market an advanced cancer treatment in Europe.

Latest press releases

May 6, 2026

Invitation to presentation of the Q1 report 2026

Investor

April 28, 2026

Oncopeptides publishes the 2025 Annual Report

Investor

Regulatory

April 16, 2026

Annual General Meeting in Oncopeptides

Regulatory

April 13, 2026

Preclinical data on novel NK-Cell engager to be presented at the AACR Annual Meeting 2026

Science

March 31, 2026

Number of shares and votes in Oncopeptides

Investor

Regulatory

March 17, 2026

Outcome in Oncopeptides’ rights issue

Regulatory

March 16, 2026

Oncopeptides initiates MARINA study to strengthen real-world evidence for Pepaxti in Germany

Science

March 13, 2026

European Journal of Haematology: Real-World Data reinforces Pepaxti’s role in treatment sequencing for multiple myeloma

Science

Latest news

May 8, 2026

Launching: Oncopeptalks as a podcast

Investor

March 23, 2026

CEO Sofia Heigis presented at Redeye event Commercialization in Life Science

Investor

March 20, 2026

Sofia Heigis presented and interviewed at Stockholm Corporate Finance Life Science Days

Investor

March 16, 2026

Oncopeptides initiates MARINA study to strengthen real-world evidence for Pepaxti in Germany

Science

March 13, 2026

European Journal of Haematology: Real-World Data reinforces Pepaxti’s role in treatment sequencing for multiple myeloma

Science

March 11, 2026

CEO Sofia Heigis presents Oncopeptides at Aktiespararna

Investor

March 9, 2026

Oncopeptides secures fast-track designation for Window-of-Opportunity study in glioblastoma

Science

March 5, 2026

Biostock: presentation and interview with Sofia Heigis

Investor

April 29, 2026

The final Oncopeptalks

In the latest, and “final”, Oncopeptalks, Sofia covers, among other things, congress season, and David provides some updates from the communications side – including that Oncopeptalks will take on a new shape in the future.